Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00006166 · ClinicalTrials.gov registry record · Phase 3
North American Study for the Treatment of Refractory Ascites (NASTRA)
A Phase 3 study, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
- Completed
- Registry status
- Phase 3
- Development phase
NCT00006166 is a Phase 3 study that has completed, run by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
The verdict
NCT00006166, a Phase 3 study, has completed, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
- COMPLETED
- Registry status
- Phase 3
- Development phase
Study Summary
The NASTRA Clinical Trial is a multi-center, randomized, controlled clinical trial designed to determine if treatment with transjugular intrahepatic portasystemic shunts (TIPS) is superior to high volume paracentesis (total paracentesis, TP) for the treatment of refractory ascites due to cirrhosis. Only patients with clinically tense symptomatic ascites (shortness of breath, umbilical hernia, abdominal pain and/or distension, and/or limitation of activity) who have either diuretic-resistant ascites or diuretic-intractable ascites are being studied.
Interventions
- PROCEDURE Transjugular intrahepatic portasystemic shunts (TIPS)
- PROCEDURE Total paracentecis (TP)
Trial Details
| Field | Value |
|---|---|
| Start Date | 1997-03 |
| Est. Completion | 2001-10 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00006166
The ClinicalTrials.gov registry entry for NCT00006166 describes a study currently listed as completed, categorized as Phase 3. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which has 490 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Transjugular intrahepatic portasystemic shunts (TIPS) is the first listed.
NCT00006166 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00006166 about?
NCT00006166 is a clinical study titled "North American Study for the Treatment of Refractory Ascites (NASTRA)". The NASTRA Clinical Trial is a multi-center, randomized, controlled clinical trial designed to determine if treatment with transjugular intrahepatic portasystemic shunts (TIPS) is superior to high volume paracentesis (total paracentesis, TP) for the treatment of refractory ascites due to cirrhosis. ...
What is the current status of trial NCT00006166?
This trial is currently completed. It is a Phase 3 study. The study started on 1997-03. Estimated completion is 2001-10.
What interventions are being tested in trial NCT00006166?
The interventions under investigation include: Transjugular intrahepatic portasystemic shunts (TIPS) (PROCEDURE), Total paracentecis (TP) (PROCEDURE).
Who is sponsoring clinical trial NCT00006166?
This trial is sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which has 490 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.